Evidence map›Paper›PMID 40256525›Full record

ReviewACS omega2025

Metal Nanoparticles Produced Using Autotrophs and Their Bioproducts: A Comparative Overview between Photosynthesizing Taxonomic Groups.

Mateus Fernandes Oliveira, Leonardo César Moraes, Cleber Cunha Figueredo

Abstract readReview
In one paragraph

Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mateus Fernandes OliveiraDepartamento de Botânica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte, Minas Gerais 31270-901, Brazil.ORCID https://orcid.org/0000-0002-8542-4368
Leonardo César MoraesDepartamento de Botânica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte, Minas Gerais 31270-901, Brazil.
Cleber Cunha FigueredoDepartamento de Botânica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte, Minas Gerais 31270-901, Brazil.ORCID https://orcid.org/0000-0002-6248-1327

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metal nanoparticles (MNPs) exhibit unique properties influenced by their size, shape, and dispersion uniformity. They can be synthesized via chemical methods or green synthesis, commonly using plant or microorganism extracts as reducing and stabilizing agents. This eco-friendly approach is valued, but the literature is unclear about which taxonomic groups should be targeted to obtain certain types of MNPs. Given the ongoing growth of research in this area, this study offers a comparative overview that helps identify patterns and gaps in the current knowledge. This study reviewed 485 articles, describing 652 monometallic and 10 bimetallic nanoparticles synthesized using photosynthesizing organisms' extracts. Angiosperms and cyanobacteria were the most utilized groups. Silver and gold nanoparticles were the most studied MNPs. Gold nanoparticles' size varied with taxonomic groups, but they were smaller than the silver nanoparticles synthesized by the same group. Antimicrobial activity was the most common application, highlighting the potential of green-synthesized MNPs. This study provides valuable insights for optimizing sustainable nanoparticle production since knowledge about the specificities of different photosynthesizing taxa can be useful for directing efforts and enhancing the efficiency and precision of green-synthesized MNPs.

Identifiers

PMID40256525
PMCPMC12004176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.